Savers Value Village Inc Initiation

William Blair initiated research coverage of Savers Village Value, Inc. (SVV $7.02), the largest for-profit thrift operator in the U.S. and Canada.

Zillow Group Inc Initiation

William Blair initiated research coverage of Zillow Group, Inc. (Z $62.47), the leader among home search portals in visitor traffic.

How Do We Produce Enough Food for Everyone in a More Crowded and Thirsty World?

William Blair Biotech Equity Research Head Discusses Outlook for COVID-19 Vaccines

Tim Lugo discusses unprecedent efforts of vaccine development.

N-able, Inc. Initiation

William Blair initiated research coverage of N-able, Inc. (NABL $14.22). N-able sells remote monitoring and management (RMM), security and data protection, and business management solutions to managed service providers (MSPs) worldwide.

Kinnate Biopharma Inc Initiation

William Blair initiated research coverage of Kinnate Biopharma Inc. (KNTE $22.64), a development-stage biopharmaceutical company focused on discovering and developing small molecule kinase inhibitors for genetically defined cancers.

ON24, Inc. Initiation

William Blair & Company initiated research coverage of ON24, Inc. (ONTF $55.26). ON24 is a digital experience platform that enables businesses to run interactive webinars and virtual event experiences with a focus on driving customer engagement and converting revenue.

908 Devices Inc Initiation

William Blair & Company initiated research coverage of 908 Devices Inc. (MASS $52.91). Boston-based 908 Devices delivers high-quality mass spectrometry to a broad set of users at the point of need. The company does this through an innovative suite of purpose-built handheld and desktop mass spectrometry devices that are smaller and more accessible than conventional lab instruments.

Fstar Therapeutics Inc and Merus NV Initiation

William Blair initiated research coverage of F-star Therapeutics, Inc. (FSTX $10.37) and Merus N.V. (MRUS $23.00), which are developing immuno-oncology therapies in the evolving field of bispecific and multispecific antibodies.

Privia Health Group Inc Initiation

William Blair initiated research coverage of Privia Health Group, Inc. (PRVA $30.08), a technology-enabled care management organization. Privia works with more than 2,700 providers and helps manage more than 3 million patients under a wide variety of fee-for-service and value-based care delivery arrangements.